INOVIO PHARMACEUTICALS, INC. (INO) Stock Profile — Insider Trades & Financials

Revenue$0

Net Income$3.8M

EPS$-2.12

Market Cap$72.5M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Jacqueline Shea, Ph.D.

CEO & Executive Director

Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development.

Founded: 1983
Employees: 262
Headquarters: PLYMOUTH MEETING, PA, United States
Website

⚡

Core Efficiency

ROE?

15.62%

ROA?

5.07%

D/E Ratio?

2.08

📊

Profitability Ratios

Current Ratio?

1.40

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Aug 18, 2026 (in 133 days)

Annual Report (10-K) — Based on filing pattern

Aug 18, 2026

Predicted10-K

Mar 12, 2026

10-KQ4 20250d after period end

Mar 12, 2026

10-KFY 202571d after period end

Nov 10, 2025

10-QQ3 20253d after period end

Aug 12, 2025

10-QQ2 20254d after period end

May 13, 2025

10-QQ1 20254d after period end

Mar 18, 2025

10-KQ4 20246d after period end

Mar 18, 2025

10-KFY 202577d after period end

Nov 14, 2024

10-QQ3 20242d after period end

Loading company sections...

INOVIO PHARMACEUTICALS, INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness